Editing Openai/7ac35a1d-067a-425d-a18f-ef913eac191d (section)

===== #### =====
# Unproven Market Demand: Without validation, there's uncertainty about the level of consumer interest and willingness to pay for your personalized healthcare solutions.
# Higher Risk: Investing heavily in the DTC model without validation can be risky, as it may require significant resources without guaranteed returns.
# Resource Allocation: Focusing on validating the DTC model will require time and resources that could be allocated elsewhere.

====== - Prioritize B2B Model: Shift primary focus to the B2B licensing model, which has a clearer and potentially faster path to market validation and profitability. ======
* DTC Validation as Secondary Goal: Treat DTC validation as a secondary goal. Conduct smaller-scale pilots and market tests to gauge consumer interest without overcommitting resources.
* Use B2B Success to Support DTC: Leverage the success and credibility of the B2B model to support and validate the DTC offering in the future. Successful case studies from practitioners can enhance consumer trust and interest.
* Risk Mitigation: By prioritizing the B2B model, you mitigate the risk of relying on an unvalidated DTC market, ensuring a more secure foundation for business growth.